Icon (ICLR) Consolidated Net Income (2009 - 2026)
Icon's (ICLR) quarterly Consolidated Net Income came in at $111.8 million in Q2 2026, down 31.05% year-over-year from $162.2 million in Q2 2025, and down 25.64% quarter-over-quarter from $150.4 million in Q1 2026.
Analysis
Icon (ICLR) Consolidated Net Income (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Consolidated Net Income for 18 consecutive years, with $111.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Consolidated Net Income fell 31.05% year-over-year to $111.8 million in Q2 2026; TTM through Jun 2026 was $506.5 million, a 44.02% decrease from a year earlier, with the FY2025 full-year figure at $873.4 million, down 14.45% from the prior year.
- Consolidated Net Income was $111.8 million for Q2 2026 at Icon, down from $150.4 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $272.0 million in Q3 2024 and troughed at $73.8 million in Q3 2025.
- A 5-year average of $167.9 million and a median of $156.3 million in 2025 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income surged 301.75% in 2022 and plunged 72.85% in 2025, its largest moves.
- Over 5 years, Consolidated Net Income stood at $139.7 million in 2022, then advanced by 3.86% to $145.1 million in 2023, then jumped by 85.59% to $269.2 million in 2024, then plunged by 36.66% to $170.5 million in 2025, then sank by 34.42% to $111.8 million in 2026.
- The last three Consolidated Net Income figures came in at $111.8 million (Q2 2026), $150.4 million (Q1 2026), and $170.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 241.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 111.81 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -760,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.28 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.81 Mn |
| Mar 31, 2026 | 150.37 Mn |
| Dec 31, 2025 | 170.51 Mn |
| Sep 30, 2025 | 73.85 Mn |
| Jun 30, 2025 | 162.17 Mn |
| Mar 31, 2025 | 201.51 Mn |
| Dec 31, 2024 | 269.21 Mn |
| Sep 30, 2024 | 272.00 Mn |
| Jun 30, 2024 | 193.60 Mn |
| Mar 31, 2024 | 244.09 Mn |
| Dec 31, 2023 | 145.05 Mn |
| Sep 30, 2023 | 165.29 Mn |
| Jun 30, 2023 | 116.96 Mn |
| Mar 31, 2023 | 118.41 Mn |
| Dec 31, 2022 | 139.66 Mn |
| Sep 30, 2022 | 203.18 Mn |
| Jun 30, 2022 | 145.10 Mn |
| Mar 31, 2022 | 139.33 Mn |
| Dec 31, 2021 | 106.39 Mn |
| Sep 30, 2021 | -100.71 Mn |